Cocaine and able: drug runners innovate

Cocaine and able: drug runners innovate

‏التالي

Lone goals: will US-Israel war aims diverge?

As Israel continues to pound Iran and expands its offensive against Hizbullah in Lebanon, there are rumblings of disunity with America over the path and goal of the conflict. Why now is the time to buy rubbish stocks. And celebrating the life of grand-clown Philippe Gaulier. Gues ...  عرض المزيد

Blood from a drone: Iran’s deadly arsenal

Iran continues to retaliate against attacks with ferocity. Though many of its ballistic missile facilities have been razed, its vast drone armoury is powerful and destructive. Who will benefit from India’s boom in data centres? And why giant board games are not child’s play. Gues ...  عرض المزيد

‏حلقات موصى بها

Economies of sail: migrant-smuggling entrepreneurs
Economist Podcasts

More than 36,000 migrants crossed the English Channel in small boats last year. Our correspondent investigates the increasingly sophisticated business strategies of the criminals who smuggle them. As the planet heats, wildfires in East Asia are becoming fiercer and more frequent ...  عرض المزيد

Grand theft global: the business of street crime
Economist Podcasts

Car and phone theft were once the preserve of petty crooks in London. Now they underpin a vast and spreading international criminal network. Why you should consider consulting a new oracle for making big life decisions: an economist. And the cult of the private chef.Listen to wha ...  عرض المزيد

Drug war: Trump takes on big pharma
Economist Podcasts

Drugs in America often cost more than three times as much as those elsewhere. But Donald Trump’s plan to cut prescription costs and impose tariffs may have unintended consequences for consumers. Inside North Korea’s crypto-heist: from hermit kingdom to hacking kingdom (10:45). An ...  عرض المزيد

Money Talks: Why weight-loss drugs will reshape the world
Money Talks from The Economist

More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs th ...

  عرض المزيد